dihexa resistant to peptidases Dipeptidyl peptidase 1 inhibitors for inflammatory respiratory diseases: mechanisms, clinical trials, and therapeutic prospects Dihexa (PNB-0408) | c-Met/HGFR Activator
Description
The therapeutic goals of B 12 treatment are the reversal of metabolic abnormalities and the prevention or reduction of clinical symptoms (fig 1)
Use a 31-gauge, 5/16-inch (8 mm) needle on a U-100 insulin syringe
That's not always very obvious
Protocols usually differ in the starting dose, target dose, number of doses required, time intervals between doses, escalation of drug concentration from dose to dose, and route of administration
